Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

54.9K
Overview
54.9K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

2.0K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
2.0K
Neuroplasticity01:01

Neuroplasticity

2.3K
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
2.3K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

807
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
807

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smart Biomaterials Shaping the Future of Dentistry: A Comprehensive Review.

Cureus·2026
Same author

Pharmacogenomics of surgical stress response in elective abdominal surgeries.

Bioinformation·2026
Same author

Managing medication-related osteonecrosis of jaw: A prospective observational study.

Bioinformation·2026
Same author

Comparison between open and closed reduction techniques for mandibular fractures: A systematic review.

Bioinformation·2026
Same author

The interplay between sinus pathology and dental infections.

Bioinformation·2026
Same author

Potential use of liquid biopsy in diagnosing oral malignancies.

Bioinformation·2026

Related Experiment Video

Updated: Mar 20, 2026

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

8.0K

Neuroprotectants: The Next Frontier in Neurology.

Patel Khushi1, Nisha Jayantilal Parmar2, Rahul Daga3

  • 1Department of Internal Medicine, Surat Medical Institute of Medicine and Research (SMIMER), Surat, Gujarat, India.

Journal of Pharmacy & Bioallied Sciences
|March 19, 2026
PubMed
Summary
This summary is machine-generated.

Neuroprotective agents show promise in protecting the brain from damage, but clinical success is limited. Future research and targeted treatments may improve outcomes for neurological disorders.

Keywords:
Alzheimer’s diseasebrain injuryclinical researchfuture trialsnerve protectionneuroprotectantsstroke

More Related Videos

Strategies for Study of Neuroprotection from Cold-preconditioning
16:27

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

15.3K
Spinal Cord Neurons Isolation and Culture from Neonatal Mice
07:49

Spinal Cord Neurons Isolation and Culture from Neonatal Mice

Published on: July 11, 2017

20.6K

Related Experiment Videos

Last Updated: Mar 20, 2026

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

8.0K
Strategies for Study of Neuroprotection from Cold-preconditioning
16:27

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

15.3K
Spinal Cord Neurons Isolation and Culture from Neonatal Mice
07:49

Spinal Cord Neurons Isolation and Culture from Neonatal Mice

Published on: July 11, 2017

20.6K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurology

Background:

  • Neurodegenerative diseases and brain injuries pose significant health challenges.
  • Neuroprotectants aim to shield the brain and nervous system from damage.
  • Current treatments for neurological disorders have limitations.

Purpose of the Study:

  • To review various types of neuroprotective agents.
  • To analyze the challenges hindering clinical translation of neuroprotectants.
  • To explore future directions for neuroprotective therapies.

Main Methods:

  • Literature review of neuroprotective agents.
  • Analysis of mechanisms of action (e.g., anti-inflammatory, anti-apoptotic, improved blood flow).
  • Examination of factors affecting clinical trial success.

Main Results:

  • Diverse neuroprotective agents exist with potential benefits.
  • Many agents show efficacy in preclinical studies but limited success in human trials.
  • Key challenges include delayed treatment, poor brain penetration, and patient variability.

Conclusions:

  • Neuroprotective drug development faces significant hurdles.
  • Advancements in technology and targeted delivery are crucial for future success.
  • Improved understanding and testing methodologies are needed for effective neuroprotective treatments.